AdaptHealth (NASDAQ:AHCO) Price Target Lowered to $11.00 at UBS Group
AdaptHealth (NASDAQ:AHCO – Get Free Report) had its price objective lowered by equities research analysts at UBS Group from $12.00 to $11.00 in a research note issued on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group’s price target suggests a potential upside of 25.28% from the company’s current price. […]
AdaptHealth (NASDAQ:AHCO – Get Free Report) had its price objective lowered by equities research analysts at UBS Group from $12.00 to $11.00 in a research note issued on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group’s price target suggests a potential upside of 25.28% from the company’s current price. […]
